心肺運動測試 (CPET) 市場規模、佔有率和成長分析：按產品、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年心肺運動測試（CPET）市場規模為35.3億美元，從2023年的37億美元成長到2031年的37億美元，預測成長期內（2024-2031年）複合年成長率為4.7%。至73 億美元。

心血管疾病對全球醫療保健產業來說是一個重大且不斷升級的挑戰，需要緊急關注和有效的診斷方法。一個引人注目的例子是歐洲心臟網路2021年發布的資料，凸顯了心血管疾病對整個歐盟（EU）的嚴重影響。研究發現，該地區有超過6,000萬人患有心血管疾病，每年新診斷病例近1,300萬例。這種高盛行率凸顯了對預防措施的迫切需要，包括廣泛採用壓力測試方法，以實現心臟病的早期發現和介入。心血管疾病的負擔日益加重，給全世界的衛生系統帶來了巨大的壓力，這凸顯了需要採取全面的策略和先進的診斷工具來應對這一日益嚴重的公共衛生挑戰。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價值鏈分析
• 價格分析
• Start-Ups分析
• 監管環境
• 專利分析
• 管道分析
• 關鍵成功因素
• 市場吸引力指數
• 競爭程度
• 主要投資機會
• 生態系繪圖

心肺運動測試 (CPET) 市場：按產品

• 市場概況
• 單光子發射斷層掃描 (SPECT)
• 心肺運動測試（CPET）系統
• 心臟超音波圖
• 脈動式血氧監測儀系統
• 壓力血壓計
• 其他

心肺運動測試（CPET）市場：依應用分類

• 市場概況
• 氧氣攝入量
• 二氧化碳
• 分鐘通氣量
• 無氧代謝閾值（AT）

心肺運動測試 (CPET) 市場：按最終用戶分類

• 市場概況
• 診斷中心
• 門診中心
• 診所/醫院
• 其他

按地區分類的心肺運動測試 (CPET) 市場規模

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• COSMED SRL（Italy）
• Vyaire Medical Inc.（USA）
• MGC Diagnostics Corporation（USA）
• Hill-Rom Holdings Inc.（USA）
• GE Healthcare（USA）
• Koninklijke Philips NV（Netherlands）
• Nihon Kohden Corporation（Japan）
• Schiller AG（Switzerland）
• Masimo Corporation（USA）
• Cardinal Health（USA）
• CareFusion Corporation（USA）
• SunTech Medical, Inc.（USA）
• Geratherm Medical AG（Germany）
• Spacelabs Healthcare（USA）
• Welch Allyn（USA）
• Microlife Medical Home Solutions Inc.（Switzerland）
• Medisoft SA（Belgium）
• CAIRE Inc.（USA）
• Becton, Dickinson and Company（USA）

Cardiopulmonary Exercise Testing Market size was valued at USD 3.53 billion in 2022 and is poised to grow from USD 3.70 billion in 2023 to USD 7.3 billion by 2031, growing at a CAGR of 4.7% in the forecast period (2024-2031).

Cardiovascular diseases pose a significant and escalating challenge for the global healthcare sector, demanding urgent attention and effective diagnostic approaches. A striking example is data published by the European Heart Network in 2021, highlighting the profound impact of cardiovascular diseases across the European Union. According to the report, more than 60 million individuals in the region live with cardiovascular disease, with nearly 13 million new cases diagnosed annually. This high prevalence underscores the critical necessity for proactive measures, including widespread adoption of stress testing procedures, to enable early detection and intervention in heart diseases. The growing burden of cardiovascular conditions places substantial pressure on healthcare systems worldwide, underscoring the need for comprehensive strategies and advanced diagnostic tools to address this escalating public health challenge.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cardiopulmonary Exercise Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cardiopulmonary Exercise Testing Market Segmental Analysis

The cardiopulmonary exercise testing market is segmented into product, application, end user, and region. Based on product, the cardiopulmonary exercise testing market is segmented into single-photon emission computed tomography, cardiopulmonary exercise testing systems, echocardiogram, pulse oximeters, stress blood pressure monitors and others. Based on application, the market is segmented into oxygen uptake, carbon dioxide, minute ventilation, and anaerobic threshold. Based on end-user, the cardiopulmonary exercise testing market is segmented into diagnostic centers, ambulatory centers, clinics and hospitals and others. Based on region, the cardiopulmonary exercise testing market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.

Drivers of the Cardiopulmonary Exercise Testing Market

The integration of cardiopulmonary exercise testing (CPET) with telemedicine platforms and simple wearable devices represents a transformative advancement in healthcare. This integration empowers individuals through remote monitoring and enables home-based research. Telemedicine platforms allow patients to undergo CPET from the convenience of their homes, overcoming geographical constraints and broadening access to essential health services. The inclusion of wearable devices enhances this approach further, as they enable individuals to capture real-time data and transmit it to healthcare providers. This plays a crucial role in preventive healthcare, early detection, and continuous management of cardiopulmonary conditions.

Restraints in the Cardiopulmonary Exercise Testing Market

The growth of the cardiopulmonary exercise testing market faces challenges due to the considerable costs involved in these diagnostic procedures. The high expenses associated with acquiring, installing, and maintaining cardiopulmonary exercise testing equipment serve as a substantial barrier to market expansion. This financial hurdle could restrict access to these testing methods for healthcare providers and patients alike, thereby potentially slowing down the adoption of cardiopulmonary exercise testing on a broader scale. Economic factors related to these tests may present difficulties for healthcare facilities, especially in areas with limited healthcare budgets.

Market Trends of the Cardiopulmonary Exercise Testing Market

The cardiopulmonary exercise testing market is set to expand, driven by a variety of exercise testing systems offered by major industry players, each offering numerous benefits and continuous advancements. A notable example occurred in May 2022, when MGC Diagnostics, a leading global medical technology company, announced a strategic collaboration with UK-based med-tech firm Bedfont Scientific Ltd. Known for its expertise in breath analysis, Bedfont Scientific has developed the NObreath fractional exhaled nitric oxide test monitor, suitable for both hospital and remote settings. Such collaborative ventures and partnerships among key industry leaders are expected to significantly contribute to the growth of the cardiopulmonary exercise testing market. These initiatives underscore a commitment to introducing cutting-edge technologies and solutions, driving expansion in this sector over the forecast period.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Pricing Analysis
• Start Up Analysis
• Regulatory Landscape
• Patent Analysis
• Pipeline Analysis
• Key Success Factors
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Cardiopulmonary Exercise Testing Market by Product

• Market Overview
• Single-photon Emission Computed Tomography
• Cardiopulmonary Exercise Testing Systems
• Echocardiogram
• Pulse Oximeters
• Stress Blood Pressure Monitors
• Others

Cardiopulmonary Exercise Testing Market by Application

• Market Overview
• Oxygen Uptake
• Carbon Dioxide
• Minute Ventilation
• Anaerobic Threshold

Cardiopulmonary Exercise Testing Market by End User

• Market Overview
• Diagnostic Centers
• Ambulatory Centers
• Clinics & Hospitals
• Others

Cardiopulmonary Exercise Testing Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• COSMED SRL (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vyaire Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MGC Diagnostics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hill-Rom Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips NV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schiller AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Masimo Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareFusion Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SunTech Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Geratherm Medical AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spacelabs Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Welch Allyn (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microlife Medical Home Solutions Inc. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisoft SA (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CAIRE Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments